Koers Guangdong Taiantang Pharmaceutical Co., Ltd.
Aandelen
002433
CNE100000Q92
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,54 CNY | -5,26% | -26,03% | -77,22% |
Omzet 2021 | 2,26 mld. 312 mln. 292 mln. | Omzet 2022 | 725 mln. 100 mln. 93,54 mln. | Marktkapitalisatie | 3,35 mld. 462 mln. 432 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -803 mln. -111 mln. -104 mln. | Nettowinst (verlies) 2022 | -823 mln. -114 mln. -106 mln. | EV/omzet 2021 | 3,17 x |
Nettoschuld 2021 | 1,45 mld. 200 mln. 187 mln. | Nettoschuld 2022 | 1,33 mld. 183 mln. 171 mln. | EV/omzet 2022 | 6,45 x |
K/w-verhouding 2021 |
-7,1
x | K/w-verhouding 2022 |
-4,08
x | Werknemers | 955 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 75,11% |
1 dag | -5,26% | ||
1 week | -26,03% | ||
Lopende maand | -56,45% | ||
1 maand | -64,47% | ||
3 maanden | -78,05% | ||
6 maanden | -78,91% | ||
Lopend jaar | -77,22% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Shao Bin Ke
CEO | Chief Executive Officer | 45 | 16-05-07 |
Xiang Yu
DFI | Director of Finance/CFO | 54 | 26-12-12 |
Qiu Hua Xu
BRD | Director/Board Member | 61 | 16-05-13 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Shao Fang Ke
BRD | Director/Board Member | 50 | 05-01-08 |
Wei Quan Zhang
BRD | Director/Board Member | 44 | 18-02-09 |
Yin Song Chen
CHM | Chairman | 60 | 27-10-20 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 0,54 | -5,26% | 654 600 |
25-04-24 | 0,57 | -5,00% | 623 600 |
24-04-24 | 0,6 | -4,76% | 2 151 600 |
23-04-24 | 0,63 | -4,55% | 1 054 400 |
22-04-24 | 0,66 | -4,35% | 1 285 900 |
slotkoers Shenzhen S.E., 26 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-77,22% | 60,33 mln. | |
-15,13% | 4,49 mld. | |
-9,75% | 3,06 mld. | |
+2,14% | 3,04 mld. | |
-6,82% | 2,61 mld. | |
+47,87% | 1,81 mld. | |
+0,09% | 1,66 mld. | |
-7,89% | 1,63 mld. | |
-12,97% | 1,55 mld. | |
+33,40% | 1,41 mld. |